Harte-Hanks Inc Dossier
|
SectorIndustrials IndustryAdvertising Beta (adjusted)0.40 Intrinsic Value $5.97median of 2 methodsbased on filings through 30 Jun 2026 Market Price $4.54Price as of 1 Oct 2026 UndervaluedIntrinsic value is 31% above the market price −50% · IV below pricenear fair value ±15%IV above price · +50% Data confidence Sign in to view data confidence Market Cap $33.8M Enterprise Value $31.7M Shares Outstanding 7.4M diluted Last ex-dividend26 Feb 2016 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Harte Hanks has successfully executed its cost-reduction program under 'Project Elevate,' leading to a dramatic narrowing of its net loss from $4.15 per share in 2024 to $0.11 per share in 2025, and achieving a debt-free balance sheet with solid liquidity. However, the company continues to face persistent top-line pressure due to legacy headwinds, with Q1 2026 revenue declining 10.3% year-over-year. While the strategic partnership with Samsung in Greenville, SC, and AI-enabled CX initiatives show promise, a 'Hold' rating is recommended until the company demonstrates sustained organic revenue stabilization and consistent profitability. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario Legacy print and direct mail declines accelerate faster than digital CX growth, or the loss of a major client among the top 25 severely impacts the top line, leading to renewed cash burn and margin compression. Base CaseCentral scenario The company continues to stabilize its margins through Project Elevate cost savings, achieving positive EBITDA throughout 2026. Revenue remains flat to slightly down as legacy declines offset new business wins in priority sectors. Bull CaseUpside scenario Successful execution of Project Elevate drives $16 million in cumulative cost savings through 2026, significantly expanding EBITDA margins. Additionally, the transition to higher-margin digital services, exclusive healthcare data partnerships (such as ADS Data Direct), and new customer care hubs (like the Samsung-anchored Greenville facility) will stabilize and scale revenues. Scenarios reflect our research view at the research date. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |